|
|
|
| November 29, 2004 |
Columbia Researchers Identify Drug as Therapeutic Candidate For Spinal Muscular Atrophy
Researchers publish article entitled "Indoprofen Upregulates the Survival Motor Neuron Protein through a Cyclooxygenase-Independent Mechanism" in the journal "Chemistry & Biology", by Lunn MR, Root DE, Martino AM, Flaherty SP, Kelley BP, Coovert DD, Burghes AH, Man NT, Morris GE, Zhou J, Androphy EJ, Sumner CJ, Stockwell BR
|
|
|
| July 28, 2004 |
General SMA Chat
Chat Transcript with Dr. Kathryn Swoboda
|
|
|
| July 2, 2004 |
Research Question and Answer Session from 2004 Family Conference
Transcript of Research Q&A, which included Drs. Chris Spancake, Arthur Burghes, Thomas Crawford, and Kathryn Swoboda
|
|
|
| June 26, 2004 |
Research Update Slides from 2004 Family Conference
Summary of 2004 FSMA Research Activities by Christopher Spancake, FSMA Research Director
|
|
|
| January 7, 2004 |
FSMA and deCODE Open Screening Capabilities to Third-Party Compounds
Latest stage in aggressive drug development drive for Spinal Muscular Atrophy
|
|
|
| January 1, 2004 |
NINDS Sponsored SMA Project Launched
As part of its mission to reduce the burden of neurological disease, the National Institute of Neurological Disorders and Stroke (NINDS) established the Spinal Muscular Atrophy (SMA) Project: A Collaborative Program to Accelerate Therapeutics Development for SMA in late 2003. The goal of this program is to enable the development of therapeutic candidates for the treatment of SMA.
|
|
|
|
|
|
